Specke Volker, Plesker Roland, Wood James, Coulibaly Cheick, Suling Kristen, Patience Clive, Kurth Reinhard, Schuurman Henk-Jan, Denner Joachim
Robert Koch-Institute, Berlin, Germany.
Xenotransplantation. 2009 Jan-Feb;16(1):34-44. doi: 10.1111/j.1399-3089.2009.00508.x.
Porcine endogenous retroviruses (PERVs) released from pig tissue can infect selected human cells in vitro and therefore represent a safety risk for xenotransplantation using pig cells, tissues, or organs. Although PERVs infect cells of numerous species in vitro, attempts to establish reliable animal models failed until now. Absence of PERV transmission has been shown in first experimental and clinical xenotransplantations; however, these trials suffered from the absence of long-term exposure (transplant survival) and profound immunosuppression.
We conducted infectivity studies in rhesus monkeys, pig-tailed monkeys, and baboons under chronic immunosuppression with cyclosporine A, methylprednisolone, and the rapamycin derivative. These species were selected because they are close to the human species and PERVs can be transmitted in vitro to cells of these species. In addition, the animals received twice, a C1 esterase inhibitor to block complement activation before inoculation of PERV. In order to overcome the complications of microchimerism, animals were inoculated with high titers of cell-free PERV. In addition, to enable transmission via cell-cell contact, some animals also received virus-producing cells. For inoculation the primate cell-adapted strain PERV/5 degrees was used which is characterized by a high infectious titer. Produced on human cells, this virus does not express alpha 1,3 Gal epitopes, does not contain porcine antigens on the viral surface and is therefore less immunogenic in non-human primates compared with pig cell-derived virus. Finally, we present evidence that PERV/5 degrees productively infects cells from baboons and rhesus monkeys.
In a follow-up period of 11 months, no antibody production against PERV and no integration of proviral DNA in blood cells was observed. Furthermore, no PERV sequences were detected in the DNA of different organs taken after necropsy.
These results indicate that in a primate model, in the presence of chronic immunosuppression, neither the inoculation of cell-free nor cell-associated PERV using a virus already adapted to primate cells results in an infection; this is despite the fact that peripheral blood mononuclear cells of the same animals are infectible in vitro.
从猪组织释放的猪内源性逆转录病毒(PERVs)可在体外感染特定人类细胞,因此对使用猪细胞、组织或器官的异种移植构成安全风险。尽管PERVs在体外可感染多种物种的细胞,但此前建立可靠动物模型的尝试均告失败。在首次实验性和临床异种移植中未显示PERV传播;然而,这些试验存在缺乏长期暴露(移植存活)和深度免疫抑制的问题。
我们在恒河猴、猪尾猴和狒狒中进行感染性研究,使用环孢素A、甲泼尼龙和雷帕霉素衍生物进行慢性免疫抑制。选择这些物种是因为它们与人类亲缘关系较近,且PERVs可在体外传播至这些物种的细胞。此外,动物在接种PERV前两次接受C1酯酶抑制剂以阻断补体激活。为克服微嵌合体的并发症,给动物接种高滴度的无细胞PERV。此外,为实现通过细胞 - 细胞接触传播,一些动物还接受了产病毒细胞。接种时使用灵长类细胞适应株PERV/5°,其特点是感染滴度高。该病毒在人细胞上产生,不表达α1,3半乳糖表位,病毒表面不含猪抗原,因此与猪细胞来源的病毒相比,在非人灵长类动物中免疫原性较低。最后,我们提供证据表明PERV/5°能有效感染狒狒和恒河猴的细胞。
在11个月的随访期内,未观察到针对PERV的抗体产生,也未在血细胞中观察到前病毒DNA的整合。此外,尸检后取自不同器官的DNA中未检测到PERV序列。
这些结果表明,在灵长类动物模型中,在慢性免疫抑制的情况下,使用已适应灵长类细胞的病毒接种无细胞或细胞相关的PERV均不会导致感染;尽管相同动物的外周血单核细胞在体外可被感染。